Navigation Links
Louise McCormick Joins Heska's Board of Directors
Date:1/3/2008

Ms. McCormick is a former Officer of Aetna, Inc.

LOVELAND, Colo., Jan. 2 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA) today announced that Ms. Louise McCormick has joined the company's Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO)

"We pride ourselves on our commitment to excellence in corporate governance, and a Board consisting of high quality, independent Directors is critical to this effort," said Robert Grieve, Heska's Chairman and CEO. "We are pleased Louise McCormick has chosen to join our Board. I am confident we will benefit from her significant experience and talents."

Ms. McCormick's career includes more than 25 years of experience with Aetna in various finance, strategic planning and legal positions. Her accomplishments include directing the turnaround of Aetna's field property/casualty claim operation, the restructuring and re-staffing of a centralized financial reporting function and the revamping of Aetna's corporate planning process. Ms. McCormick is currently an independent Director, chair of the Investment Committee and a member of the Ethics and Corporate Governance Committee of Foresters, a Toronto-based insurance company.

"I am impressed with Heska's commitment to animal health and recent operating performance. I am excited by the prospects for the products the company has recently launched," commented Ms. McCormick. "I am pleased to join this stellar Board and look forward to a continuation of Heska's demonstrated success."

About Heska

Heska Corporation (Nasdaq: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at http://www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. In addition, factors that could affect the business and financial results of Heska generally include the following: uncertainties related to the impact any given Director or Heska's Board of Directors as a whole may ultimately have on Heska's operating results; risks regarding the commercialization and market acceptance of products Heska has introduced recently or may introduce in the future; risks related to using historical results to predict future outcomes; risks regarding Heska's ability to successfully market, sell and distribute its products; competition; uncertainties regarding Heska's reliance on third parties to whom Heska has granted substantial marketing rights to certain of Heska's existing products; risks regarding Heska's reliance on third-party suppliers, which is substantial; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Annual Report on Form 10-K for the year ended December 31, 2006 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.


'/>"/>
SOURCE Heska Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Adult-Care.Org, After Its Initial Launch on August 28, 2007, in October 2007 Captures Attention of One of the Fastest Growing NASDAQ Companies, McCormick & Schmicks Seafood Restaurants in Marketing Partnership
2. Richard Greco Joins Mediware Board
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
5. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
6. Nick Childs Joins Grey New York as Director of Content Development
7. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
8. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
9. NASN Joins Partnership to Fight Chronic Disease
10. AstraZeneca Joins Local Walking Movement
11. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: